Document:

Rosetta
      Genomics Ltd.

    August
      15, 2004

    Glenrock
      Israel Ltd.
      ("Glenrock")

    Re: Consulting
      Agreement

    Dear
      Sirs,

    We
      are
      pleased to have the opportunity to render Glenrock's services as
      consultants
      of Rosetta (Genomics
      Ltd (the "Company").
      We
      expect
      that Glenrock's contribution as consultants of the Company
      will be of significant strategic benefit to the Company in establishing its
      business and developing its technologies.

    

    For
      the
      sake of good order we wish to set forth below in this letter agreement (the:
      “Agreement”)
      the
      terms
      and conditions of Glenrock's consultancy engagement with the
      Company:

    

    
      	1.   	
              Term. This
                Agreement will enter into effect at the initial Closing of the Company's
                contemplated
                Preferred B Investment Round for aggregate investments of at least
                $2,000,000 (the
                "Effective
                Date") and
                is subject to execution of
                such initial
                Closing. The term of this Agreement is twelve (12) months commencing
                on
                the Effective Date, unless renewed or extended
                by mutual written consent of both parties (the
                "Term").

            

      	 	 

    

    
      	2.   	
              Compensation. 

              As
                a consideration for Glenrock's consultancy services to the Company
                under
                the terms of this
                Agreement under the
                terms of this Agreement, the Company will pay Glenrock monthly
                consulting
                fees of $5,000 plus VAT for each month of consultancy (the "Consulting
                Fees”). Glenrock shall also be entitled
                to
                reimbursement of direct expenses relating to the provision of
                the Services, subject to prior approval by the Company. The Consulting
                Fees and reimbursement
                will be paid within 10 days of the
                end of each calendar month against a proper
                tax invoice.

            

      	 	 

    

    
      	3.   	
              Duties.

            

      	 	 

    

    
      	    	3.1.	
              Glenrock
                acknowledges and agrees that Glenrock's primary services to the Company
                shall include, but not be limited to (the "Services"): (i) help develop
                and implement business
                strategies for the Company, (ii) advise the Company with respect
                to
                various matters,
                including, but not limited to, the growth and development of its
                business,
                including
                the direction of the Company's staffing and financing matters and
                (iii)
                leverage Glenrock's network of industry contacts by providing the
                officers
                and other management of the Company with introductions to participants
                in
                the related industries.

            

      	 	 	 

    

    
      	    	3.2.	
              Glenrock
                agrees to render the Services in a
                professional manner
                by, including, without limitation, providing consultancy services
                to the
                Company primarily by being available to the officers and other management
                of the Company for pre-scheduled meetings or by telephone
                on reasonable “as requested” basis.

            

      	 	 	 

    

    
      	4.   	
              Confidentiality
                and Nondisclosure.

            

      	 	 

    

    
      	    	4.1.	
              Unless
                otherwise agreed to in writing by the Company, Glenrock agrees (i)
                to keep
                in strict confidence all Confidential Information (as defined herein)
                and
                not to disclose any Confidential Information, or any portion thereof,
                to
                any third party, (ii) not to use any Confidential Information (except
                within the scope of Glenrock’s duties hereunder). As used in this
                Agreement, the term "Confidential Information" refers to all inventions
                and all other business, technical and financial information (including,
                without limitation, the identity of, and information relating to,
                customers or employees) Glenrock develop, learn or obtain during
                the term
                of this Agreement that relate to any information proprietary to,
                used by
                or in the possession of the Company or its respective businesses
                or
                demonstrably anticipated business of any of the Company or that are
                received by or for any of the Company in confidence, whether or not
                reduced to writing. The foregoing limitations shall not apply to
                information that (i) was lawfully known to Glenrock before the receipt
                thereof, (ii) is learned by Glenrock from a third party that is entitled
                to disclose same, (iii) becomes publicly known other than through
                Glenrock's actions or (iv) is required by law or court order to be
                disclosed by Glenrock. In the event that Glenrock is requested pursuant
                to, or required by, applicable law or regulation or by legal process
                to
                disclose any Confidential Information, Glenrock shall provide the
                Company
                with prompt notice of such request(s) so that the Company may seek
                an
                appropriate protective order.

            

    

     

    

    
      
        
        

      

      
        1

        
          

        

      

      
        
        

      

    

     

     

    
      	    	4.2.	
              During
                the Term and for a period of twelve (12) months thereafter, Glenrock
                agrees (i) not
                to engage in any activity that is in any way directly competitive
                with
                the
                businesses of
                the Company, in the field of microRNAs (the "Field") and not to
                assist or advise any other
                person or organization in competing
                or in preparing to
                compete with the businesses
                of the Company in the Field

            

      	 	 	 

    

    
      	5.   	
              Conflicting
                Agreements.

            

      	 	 

    

    
      	    	5.1.	
              By
                signing this letter Glenrock represent to the Company that Glenrock
                has
                not entered into any agreement, in conflict with this Agreement or
                Glenrock's duties to the Company pursuant to this Agreement. Glenrock
                agrees not to violate any agreement with or rights of any third party
                or,
                except as expressly authorized by Company in writing hereafter, use
                or
                disclose Glenrock's own or any third party's confidential information
                or
                intellectual property when acting within the scope of Glenrock's
                duties
                pursuant to this Agreement or otherwise on behalf of
                Company.

            

      	 	 	 

    

    
      	    	5.2.	
              Glenrock
                further understands and acknowledges that Glenrock is
                an independent contractor
                and is responsible for all taxes, withholdings, and other similar
                statutory obligations.
                Glenrock will have no power or authority to bind, enter
                into any contract, incur
                any liability, make any representation, direct or act on behalf of
                the
                Company in connection
                with providing any Services or
                otherwise. Glenrock agrees to defend, indemnify
                and hold the Company harmless from any and all claims made by any
                entity on
                account of an alleged failure by Glenrock to satisfy any
                such tax or withholding obligations.

            

      	 	 	 

    

    
      	6.   	
              General
                Conditions.

            

      	 	 

    

    
      	    	6.1.	
              Entire Agreement.
                This Agreement represents the entire agreement of
                the parties, and shall supersede any and all previous contracts or
                understandings between
                the parties hereto,
                with respect to the subject matter hereof. This Agreement shall
                not be modified, amended or terminated except in
                a writing signed by the
                party against whom
                enforcement
                is sought.

            

      	 	 	 

    

    
      	    	6.2.	
              Governing
                Law. This
                Agreement shall he governed by and construed in accordance with
                the laws of the state of Israel, without regard to the conflicts
                of
                law provisions thereof,
                and the competent courts of Tel Aviv-Jafa shall have exclusive
                jurisdiction over
                all
                matters arising under or relating to this
                Agreement.

            

    

    

    Please
      acknowledge Glenrock's acceptance of, and agreement with,
      the
      terms of this Agreement by
      signing a counterpart of this signature page and returning
      the same to the Company at the address
      indicated above.

     

     

    
      	 	 	 
	 	Sincerely,
	 	 
	 	 
	 	Rosetta
              Genomics
              Ltd.
	 
 	 
 	 
 
	 	By:  	/s/ Dr.
              Isaac
              Bentwich
	 	
              

            
	 	Name: Dr. Isaac Bentwich
	 	Title 
              Chairman & CEO

    

     

    
      	
              ACKNOWLEDGED,
                ACCEPTED AND
                AGREED:

            
	 	 
	By: 
              	/s/ Leon
              Recanati
	 	
              

            
	
               

              By:

            	Glenrock
              Israel
              Ltd.
Leon Recanati
Title: CEO 

    

    
      	 	 	 

    

     

     

    
      
        
        

      

      
        2FINDER
      FEE AGREEMENT

     

    This
      agreement (the “Agreement”) is made as of this 22 day of March, 2006, by and
between
      Rosenram Business Development Ltd. of 52 Menachem Begin Road, Tel Aviv (the
      “Finder”); and
      Rosetta Genomics Ltd. of 10 Plant Street, Jerusalem, Israel, (the “Company”).

     

    
      	
              Whereas

            	
              The
                Company is engaged in breakthrough research and development in the
                field
                of bio-informatic detection, prediction and discovery of microRNA
                genes
                and their respective functions and utilities, and therapeutic and
                diagnostic uses based thereof; 

            
	 	 
	
              Whereas

            	
              The
                Company is seeking to complete a preferred equity round of financing
                (the
                “Financing), under
                which the Company intends to raise up to S13M (the “Investment”).

            
	 	 
	
              Whereas

            	
              the
                Finder has connections with potential investors (“Investors”) that
                may have interest in making cash investments in the Company’s equity
                (“Investment
                Transactions”);

            
	 	 
	
              Whereas

            	
              the
                Company is interested in using the Finder services, on a non exclusive
                basis, for the purposes of locating Investors and facilitating such
                Investment Transactions with them, subject to the terms and conditions
                contained herein.

            

    

     

    NOW,
      THEREFORE, in consideration of the mutual promises and conditions set forth
      herein the parties agree as follows:

     

    
      	
              1.

            	
              Finder
                Obligations.
                Finder shall act to locate Finder Contacts (as such term is defined
                herein), present them to the Company and assist the Company in negotiating
                and
                facilitating Investment Transactions with such Finder
                Contacts.

            

    

     

    
      	
              2.

            	
              Finder
                Contacts.
                The term “Finder Contact” shall mean all Investors that: (i) Finder
                introduced
                to the Company and the parties mutually agreed in writing that it
                shall be
                so considered, and (ii) with which Finder arranged meetings or discussions
                and contributed to
                facilitating Investment Transactions with, and (iii) that were
                pre-approved by the Company and are listed on Schedule
                A
                hereto as amended from time to time by the parties
                in writing. Notwithstanding anything contained herein it is clarified
                and
                declared that the conclusion of an Investment Transaction, if any,
                shall
                be at the Company’s sole discretion. The Finder shall not introduce the
                Company to any specific Investor without receiving the Company’s prior
                consent.

            

    

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    
      	
              3.

            	
              Success
                Fees.
                In the event Company enters into an agreement for an Investment
                Transaction with a Finder Contact during the Term (as defined in
                Section 6
                below) or within 3 months following the date of its expiration or
                termination (the “Determining Period”), for an Investment Transaction in
                the Financing, the Finder shall be entitled to the following
                consideration:

            

    

     

    
      	                     
              3.1.1	
              A
                cash commission of 4% of the cash investments made by Finder Contacts
                in the Financing.

            

    

     

    
      	                     
              3.1.2	
              In
                addition to the consideration specified in Section 3.1.1 above the
                Finder
                shall be entitled to an option to purchase an amount of ordinary
                shares
                of the Company equal to up to 2% of the amount of shares allotted
                by the
                Company to the Finder Contacts pursuant to the Financing at the
                price
                per share of the converted shares. The option will be valid for 36
                months
                following the closing of the
                Financing.

            

    

     

    
      	
            	
              3.2

            	
              For
                the avoidance of any doubt, the terms of the Success Fee under this
                section 3 are relevant and applicable to the Financing
                only.

            

    

     

    
      	
              4.

            	
              Payments
                and Reports.

            

    

     

    
      	4.1  	
              All
                cash amounts due to Finder hereunder shall be paid in the same currency
                in
                which
                the Company receives the Finder Investments. VAT shall be added to
                all
                payments
                against a proper VAT invoice. For the removal of doubt, it is hereby
                agreed that the Finder shall be responsible for all taxes, withholdings,
                and other similar statutory obligations. The Finder agrees to defend,
                indemnify and hold the Company harmless from any and all claims made
                by
                any entity on account of an alleged failure by the Finder to satisfy
                any
                such tax or withholding
                obligations.

            

    

     

    
      	4.2  	
              The
                Company shall inform Finder of any Financing between the Company
                and a
                Finder Contact within 30 days of its signing.

            

    

    
      
        
        

      

      
        2

        
          

        

      

      
        
        

      

    

     

    
      	
              5.

            	
              Company
                Information.
                The Company shall provide Finder with reasonable information, as
                it may deem necessary, regarding the Company, its products, services,
                technology and
                relevant markets for the purpose of Finder performing its duties
                hereunder. Subject to
                Section 2 above, the Company hereby authorizes the Finder to provide
                such
                information
                only to prospective Finder Contacts pre-approved by the Company.
                Any
                and
                all information provided by the Company to Finder is subject to the
                confidentiality clause
                in this agreement. Confidential information obtained by the Finder
                from
                the Company
                shall be subject to the terms and conditions of the Company’s
                non-disclosure agreement, as detailed in Section 8
                below.

            

    

     

    
      	
              6.

            	
              Term
                and Termination.
                The term of this Agreement is for a period of 3 months commencing
                at the date hereof (the “Term”).

            

    

     

    Either
      party may terminate this agreement on the occurrence of one of the
      following:

     

    6.1     
       by
      serving the other party a 15 days prior written notice to such
      effect;

     

    
      6.2   
           forthwith, by serving the other party a written notice, in the
        event that the other party has breached any of its undertaking hereunder
        and not
        cured such breach within 7 days
        of the non-breaching party’s notice to such effect;

    

     

    6.3    
        forthwith,
      without need for a written notice, in the event that the other party has entered
      into any liquidation, insolvency, bankruptcy or similar
      proceedings.

     

    In
      the
      event of termination of this Agreement, and if such termination is made by
      the
Company
      pursuant to Sections 6.2 or 6.3 above, the Finder shall not be entitled to
      receive
      any Success Fees not paid to them by the date of termination. In any other
      event, the provisions of Section 3 apply. Subject to the above, the Company
      may
      continue to pursue any relations with Finder Contacts following termination
      of
      this Agreement. Following termination of this Agreement, for any reason: (i)
      Finder shall immediately cease representing to third parties that it has any
      rights granted to it herein, and (ii) the Company may require Finder to return
      all documentation concerning the Company and its products in its possession
      to
      the Company. For avoidance of doubt, the provisions of Sections 7 and 8 below
      shall survive the termination of this Agreement.

     

    
      	
              7.

            	
              Intellectual
                Property.
                Finder recognizes and acknowledges that all of the Company’s IP, including
                without limitation, all the Company’s patents, patent applications,
                copyrights, trade
                names and trade marks, solely belong to the Company which is and
                shall
                remain its sole owner, and it is hereby expressly agreed that nothing
                in
                this agreement shall constitute or be considered as constituting
                a
                transfer or license of the Company’s intellectual
                property rights or any part thereof by the Company to Finder. Finder
                shall
                adhere to any reasonable instructions given to it in writing by the
                Company aimed for the protection of the Company’s trademarks and any other
                intellectual properly rights.

            

    

    
      
        
        

      

      
        3

        
          

        

      

      
        
        

      

    

     

    
      	
              8.

            	
              Confidentiality.
                Finder shall, both during the term of this Agreement and after the
                expiration
                or termination of this Agreement, hold the proprietary and confidential
                information of the Company (the “Confidential Information”) in strict
                confidence and will
                not disclose or make such Confidential Information available in any
                form
                to any third
                party or to use such Confidential Information for any purposes other
                than
                the implementation of this Agreement. Confidential Information shall
                mean
                any and all information provided to Finder by Company, whether related
                lo
                business, technology or any other matter relevant to the Company,
                excluding information which is in the public domain not as a consequence
                of a breach of any confidentiality undertaking by Finder. Without
                derogating from the generality of the above, Finder shall sign a
                Confidentiality undertaking in the form attached as Schedule B
                hereto.

            

    

     

    Finder
      undertakes to retain in strict confidence and not to disclose to any third
      party
      any information related to this Agreement, its terms and
      conditions.

     

    
      	
              9.

            	
              Independent
                Contractors.
                It is hereby expressly declared and agreed that the parties have
                entered
                this Agreement as independent contractors and this Agreement in no
                way
                establishes
                any principal - agent, employer - employee, or partnership relations
                between the parties. Nothing in this Agreement shall be construed
                as
                granting either party the power or authority to act for or on behalf
                of
                the other party, to create any undertakings on behalf of the other
                party,
                or to bind or commit the other party in respect to any such undertakings,
                except as set forth herein or as otherwise agreed to in writing between
                the parties prior to such act.

            

    

     

    
      	
              10.

            	
              Governing
                Law/ Jurisdiction.
                This Agreement shall be governed by the laws of the State
                of Israel, without regard to its conflict of law rules and the competent
                courts of Tel Aviv-Jafa
                shall have exclusive jurisdiction over all matters arising under
                or
                relating to this Agreement.

            

    

    
      
        
        

      

      
        4

        
          

        

      

      
        
        

      

    

     

    
      	
              11.

            	
              Counterparts/Entire
                Agreement.
                This Agreement may be executed in several counterparts,
                each of which shall be deemed an original and all of which shall
                together
                constitute one and the same Agreement. This Agreement constitutes
                the
                entire agreement between the Parties respecting the subject matter
                hereof
                and supersedes any and
                all prior agreements or understandings between the Parties with respect
                to
                the subject
                matter hereof, whether written or oral. Except as set forth herein,
                no
                addition or modification
                of this Agreement will be effective or binding unless in writing
                and
                executed
                by both of the Parties.

            

    

     

    [REMAINDER
      OF PAGE INTENTIONALLY LEFT BLANK]

     

    IN
      WITNESS WHEREOF the Parties, through their duly authorized representatives
      have
executed
      this Agreement on the date(s) as of the date written above.

     

     

    
      	
              ROSETTA
                GENOM1CS
                LTD.

            	 	 	
              ROSENRAM

            
	
              512921388
                __

            	 	 	
              ______________

            
	
              Rosetta
                Genomics Ltd.

            	 	 	
              Rosenram
                Business Development Ltd.

            
	
               

              By:
                Illegible

            	 	
               

            	
               

              By:
                Revital Aviram

            
	 	 	 	 
	
              Title:
                CEO

            	 	 	
              Title:
                Director

            

    

     

    
      
        
        

      

      
        5

        
          

        

      

      
        
        

      

    

     

    Schedule
      A – FINDER
      CONTACTS

     

    
      	
              1.

            	
              Rosenram
                Trustees Ltd. company no. 513767913 - $ 1,750,000 (Rafel Amiel French
                resident).

            

    

     

    
      	
              2.

            	
              Instanz
                Nominees Pty Ltd - $ 3,700,000

            

    

     

    
      	
              3.

            	
              Dolphin
                Energies Ltd. - $1,000,000 / $ 2,000,000

            

    

     

    
      
         

      

      
        6

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00109-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00109-of-00352.parquet"}]]